Immune thrombocytopenia triggered by dostarlimab in a patient with endometrial carcinoma: first reported case
Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape for various malignancies, but they are associated with a range of immunerelated adverse events, including rare hematological complications. Immune thrombocytopenia (ITP) has been reported with other antiPD1 agents such as n...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis Group
2026-12-01
|
| Seri Bilgileri: | Platelets |
| Konular: | |
| Online Erişim: | https://www.tandfonline.com/doi/10.1080/09537104.2025.2601056 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|